book attempts to coordinate the anatomical, physiological, biochemical, endocrinological, pharmacological and immunological aspects of human prostatic cancer. There are 35 contributors, from N. America, Europe and Japan. The editors have produced a conspectus of the present "state of the art" in prostatic cancer research. Hospitals and research institutes involved with prostatic disease will find this book a useful addition to their library shelves.
It is interesting to see scanning electron micrographs frankly used as purely decorative chapter headings, perhaps a just assessment of their main value in biological research R. DODGE Malignant Lymphomas other than Hodgkins's Disease. Ed. K. LENNERT (1981) . Berlin: Springer Verlag. 833 pp.
Karl Lennert, with other European collaborators, introduced the Kiel Classification of non-Hodgkins malignant lymphomas. The book is essentially a text of pathology, but some preliminary information is provided relating clinical progress to pathological type. At present, there is no completely satisfactory pathological classification ofthe non-Hodgkin's lymphomas, but this attempt, which takes into consideration immunological methods, has been well received by many pathologists in Europe. The histological, cytological and cytochemical features of each type of lymphoma are discussed at length and illustrated with high-quality photography. One section, by Kaiserling, describes the ultrastructure, and another, by Stein, the immunological basis for the Kiel classification. The English is clear, and the case for the new classification is well presented. There are many pathologists and clinicians who would not agree with several aspects of this classification and prefer another. However, the book will be a well read text for pathologists involved in the classification of this difficult group of tumours and clinicians responsible for their treatment.
The text book is for the specialist but Karl Lennert is to be congratulated on his important contribution to our understanding of lymphoma pathology. The deficiencies in relating prognosis, immunological phenotype and histology will undoubtedly be corrected in the years to come as the classification becomes more widely used.
D. CROWTHER This is definitely one of the more worthwhile appraisals in this series and offers an acceptable foundation for anyone entering the field of carcinogen screening and a useful reference source for those already in the field.
The first report is concerned with longterm assays, and details practically every pitfall of such systems. This is so important in assay systems which have so many inherent variables. Everything from the administration of the test substance, through animal caging/bedding selection, to processing of the data is discussed.
The reports on 'Mutagenesis Assays in Bacteria', 'Mutagenesis Assays in Mammalian Cells', 'Transformation in Cell Culture' and 'Cytogenetic Damage as an end point in short-term Assay systems' are well and enthusiastically presented, detailing the advatages and dis-advantages of both, the particular class of screening test and the detailed and varied methods encompassed within each class.
Perhaps the most interesting report in the book is that on 'Mutagenesis Assays with Whole Mammals'. This is an area that has been relatively poorly studied and theoretically represents the situation closest to that in real life. Conversely, the Yeast, Drosophila and DNA-repair chapters tend to demonstrate that these areas are outmoded.
A Following the successful first volume in 1979, this book will have been enthusiastically awaited by specialists in several fields, not only because it succeeds in bringing together between the same covers diverse aspects of current interferon research, but also because this research is advancing with quite exceptional rapidity simultaneously on all fronts.
Knight deals in the first chapter with the
